Phase II trial of the dual IGF-1R/IR inhibitor BMS-754807 with or without letrozole in aromatase inhibitor-resistant breast cancer.
P. Haluska
Consultant or Advisory Role - Bristol-Myers Squibb (U)
Research Funding - Bristol-Myers Squibb
A. Dhar
Employment or Leadership Position - Bristol-Myers Squibb
X. Hou
No relevant relationships to disclose
F. Huang
Employment or Leadership Position - Bristol-Myers Squibb
D. S. A. Nuyten
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
J. Park
Employment or Leadership Position - Bristol-Myers Squibb
A. H. Brodie
No relevant relationships to disclose
J. N. Ingle
No relevant relationships to disclose
J. M. Carboni
Employment or Leadership Position - Bristol-Myers Squibb
M. M. Gottardis
Employment or Leadership Position - Bristol-Myers Squibb
A. C. Wolff
No relevant relationships to disclose
F. G. Finckenstein
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb